CD8A and melanoma: These cells then process the melanoma antigens and place them onto their Major Histocompatibility Complex II (MHC II), so they can present these peptides to naïve T-cells in the lymph nodes, resulting in the activation/expansion of melanoma-specific cytotoxic CD8+ T cells [304].